Kevin J. Arquit Authors “Don’t Discount Drug Discounting”
Kevin J. Arquit, partner and Co-Chair of the antitrust practice at Kasowitz Benson Torres, has authored “Don’t Discount Drug Discounting,” published in Law360. In the article, Mr. Arquit discusses the Trump Administration’s proposal to reduce the cost of prescription drugs by passing discounts on to patients at the point of sale, and the merits of the antitrust issues raised by opponents in response to the proposal.
Kevin J. Arquit, Co-Chair of Kasowitz’s Antitrust Group, is one of the world’s top antitrust attorneys. He represents clients in high-profile antitrust litigation before the Federal Trade Commission, the Antitrust Division of the Department of Justice and numerous state and international competition authorities. Mr. Arquit also provides a wide variety of companies with ongoing antitrust counseling. He has been consistently ranked by prominent legal publications such as Chambers USA, Chambers Global, The Legal 500, Law360 and National Law Journal as a leading lawyer in his field.